Pfizer, Trump strike drug pricing deal
The deal is a victory for Trump who has pressured drugmakers to voluntarily comply with his policy priorities. If not, they will likely face regulation or high tariffs.
Today's Liberal News
By David Lim
Pfizer, Trump strike drug pricing deal
The deal is a victory for Trump who has pressured drugmakers to voluntarily comply with his policy priorities. If not, they will likely face regulation or high tariffs.
The Trump administration’s favored tactic to force companies to act
President Donald Trump is relying on drugmakers to lower U.S. prices on their own, but he might get less than he bargained for.
Pfizer, Trump strike drug pricing deal
The deal is a victory for Trump who has pressured drugmakers to voluntarily comply with his policy priorities. If not, they will likely face regulation or high tariffs.
The Trump administration’s favored tactic to force companies to act
President Donald Trump is relying on drugmakers to lower U.S. prices on their own, but he might get less than he bargained for.
Pfizer, Trump strike drug pricing deal
The deal is a victory for Trump who has pressured drugmakers to voluntarily comply with his policy priorities. If not, they will likely face regulation or high tariffs.
The Trump administration’s favored tactic to force companies to act
President Donald Trump is relying on drugmakers to lower U.S. prices on their own, but he might get less than he bargained for.
Pfizer, Trump strike drug pricing deal
The deal is a victory for Trump who has pressured drugmakers to voluntarily comply with his policy priorities. If not, they will likely face regulation or high tariffs.
The Trump administration’s favored tactic to force companies to act
President Donald Trump is relying on drugmakers to lower U.S. prices on their own, but he might get less than he bargained for.
The Trump administration’s favored tactic to force companies to act
President Donald Trump is relying on drugmakers to lower U.S. prices on their own, but he might get less than he bargained for.
Pfizer, Trump strike drug pricing deal
The deal is a victory for Trump who has pressured drugmakers to voluntarily comply with his policy priorities. If not, they will likely face regulation or high tariffs.
The Trump administration’s favored tactic to force companies to act
President Donald Trump is relying on drugmakers to lower U.S. prices on their own, but he might get less than he bargained for.
FDA to approve drug to treat autism symptoms
In a POLITICO Magazine opinion piece, leaders in Trump’s health department also caution the public to balance the risk and benefits of taking acetaminophen during pregnancy.
FDA to approve drug to treat autism symptoms
In a POLITICO Magazine opinion piece, leaders in Trump’s health department also caution the public to balance the risk and benefits of taking acetaminophen during pregnancy.
FDA to approve drug to treat autism symptoms
In a POLITICO Magazine opinion piece, leaders in Trump’s health department also caution the public to balance the risk and benefits of taking acetaminophen during pregnancy.
Trump announces crackdown on pharmaceutical advertising
The administration is planning to take regulatory action to require companies to include more drug information
Trump announces crackdown on pharmaceutical advertising
The administration is planning to take regulatory action to require companies to include more drug information
Trump announces crackdown on pharmaceutical advertising
The administration is planning to take regulatory action to require companies to include more drug information
Trump announces crackdown on pharmaceutical advertising
The administration is planning to take regulatory action to require companies to include more drug information
Trump announces crackdown on pharmaceutical advertising
The administration is planning to take regulatory action to require companies to include more drug information
Trump announces crackdown on pharmaceutical advertising
The administration is planning to take regulatory action to require companies to include more drug information
Trump announces crackdown on pharmaceutical advertising
The administration is planning to take regulatory action to require companies to include more drug information
FDA revokes emergency use of Covid-19 vaccines
The decision could make it difficult for young healthy children to get a Covid-19 shot.
FDA revokes emergency use of Covid-19 vaccines
The decision could make it difficult for young healthy children to get a Covid-19 shot.
Top vaccine regulator returns to FDA after recent firing
Vinay Prasad had been dismissed less than two weeks ago.
Top vaccine regulator returns to FDA after recent firing
Vinay Prasad had been dismissed less than two weeks ago.
Kennedy to halt $500 million in vaccine projects
The move ends investments in projects involving mRNA technology.
Kennedy to halt $500 million in vaccine projects
The move ends investments in projects involving mRNA technology.
Kennedy to halt $500 million in vaccine projects
The move ends investments in projects involving mRNA technology.
Kennedy to halt $500 million in vaccine projects
The move ends investments in projects involving mRNA technology.